Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT07006480
Status
Recruiting
Apply to this trial

Conditions

  • Diabetes Mellitus

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Real time CGM data monitoring — DEVICE
    CGM data will be monitored in real time during daytime in the hospital. Alerts about high and low glucose levels will be communicated to patient's nurse and treating providers.
  • Insulin dose adjustment based on glucometer and CGM glucose data trends — DEVICE
    Insulin dose will be modulate based on glucometer values and previous day glucose trends as recorded on CGM.
  • Share CGM data on admission and on discharge from the hospital — DEVICE
    Record 14 days' worth of CGM data prior to admission and all CGM data recorded during the hospitalization at the time of discharge from the hospital

Study Details

The purpose of this research is to prove that data generated by your real-time personal continuous glucose monitors CGMs brought in the hospital at the time of hospitalization can be monitored and safely used to guide insulin therapy aiming to improve glycemic control and to diminish the hypoglycemia and hyperglycemia episodes without negatively affecting patients' satisfaction, providers and your nurses satisfaction with how glucose is monitored and treated in the hospital.

Key Dates

Start date
Oct 1, 2025
Status verified
Oct 2025
Primary completion
Jun 14, 2026
Completion
Jun 14, 2026

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Active Comparator: Control
    patients admitted to the hospital wearing a CGM with data not monitored in real time
  • Experimental: Monitored
    patients admitted to the hospital wearing a CGM with data monitored in real time

Primary Outcome Measure

Difference in mean glucose levels between subjects in intervention vs control group [ Time Frame: From admission date to discharge date up to 8 weeks. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in FloridaJacksonvilleFlorida32224
Adrian Dumitrascu, MD
[email protected]
904-953-2000

Find similar trials in Jacksonville, FL

By research site
Mayo Clinic in Florida· Jacksonville, FL

Related Studies